OCGN updated stock price target summary. Ocugen (NASDAQ:OCGN) had its price target raised by Roth Capital from $9.00 to $10.00 in a report issued on Thursday, The Fly reports. The ⦠Learn everything you need to know about successful options trading with this three-part video course. ... Average Target Price: 12.50: Number Of Ratings: 4: ⦠The shares of Ocugen Inc (NASDAQ: OCGN) have received a price target increase from $9 to $10 by Roth Capital. View which stocks are hot on social media with MarketBeat's trending stocks report. Ocugen (NASDAQ:OCGN) Price Target and Consensus Rating 4 Wall Street analysts have issued ratings and price targets for Ocugen in the last 12 months. Ocugen (NASDAQ:OCGN) had its target price boosted by Cantor Fitzgerald from $1.00 to $4.00 in a research note issued to investors on Wednesday morning, The Fly reports. Fundamental company data provided by Zacks Investment Research. Ocugen Inc stock price prediction is an act of determining the future value of Ocugen shares using few different conventional methods such as EPS estimation, analyst consensus, or fundamental intrinsic valuation.The successful prediction of Ocugen stock future price could yield a significant profit. Export data to Excel for your own analysis. Cantor Fitzgerald raised their price target on shares of Ocugen from $1.00 to $4.00 and gave the stock an overweight rating in a research note on ⦠Roth Capital is very positive to OCGN and gave it a "Buy" rating on March 04, 2021. The high price target for OCGN is $10.00 and the low price target for OCGN is $0.70. Ocugen (NASDAQ:OCGN) had its price objective hoisted by Roth Capital from $1.00 to $8.00 in a report published on Wednesday, The Fly reports. Price targets can be assigned to all types of securities, from complex investment products to stocks such as Ocugen Inc and even bonds. Cantor Fitzgerald currently has an overweight rating on the stock. View our full suite of financial calendars and market data tables, all for free. Additionally, you may evaluate how the addition of Ocugen to your portfolios can decrease your overall portfolio volatility. The shares of Ocugen Inc (NASDAQ: OCGN) have received a price target increase from $9 to $10 by Roth Capital. Hold). Do Not Sell My Information. Upgrade to MarketBeat Daily Premium to add more stocks to your watchlist. Ocugen price target raised to $4 from $1 at Cantor Fitzgerald. There are currently 1 hold rating and 3 buy ratings for the stock, resulting in a consensus rating of "Buy.". HC Wainwright reaffirmed a hold rating on shares of Ocugen in a research report on [â¦] Looking for new stock ideas? MarketBeat does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security. Guides. If the target price is unavailable, it is most likely because there were not enough analyst opinions to come up with a consensus estimate. To see all exchange delays and terms of use please see disclaimer. Ocugen (OCGN) Dips More Than Broader Markets: What You Should Know Mar 08 / Zacks.com - Paid Partner Content This Is the Cheapest Coronavirus Vaccine Stock Right Now Ocugen NASDAQ Updated Mar 9, 2021 1:14 PM. MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. If the target price is unavailable, it is most likely because there were not enough analyst opinions to come up with a consensus estimate. In that case, then, we find that the current price level is -49.4% off the targeted high while a plunge would see the stock lose -95.57% from current levels. Zacks Investment Research cut shares of Ocugen from a [â¦] This means that the current price is justified in his opinion. These are the details. Ocugen's share price could stay at $8.38 by Mar 3, 2022. The average price target represents a 39.35% increase from the last price of $8.97. The stock price of Ocugen Inc (NASDAQ: OCGN) has received a price target increase by Chardan Capital from $0.70 to $13. The high price target for OCGN is $10.00 and the low price target for OCGN is $0.70. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. Get short term trading ideas from the MarketBeat Idea Engine. © 2021 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. They currently have a buy rating on the stock. ... OCUGEN INC OCGN STOCK CHART ANALYSIS | OCUGEN ⦠Anheuser-Busch Inbev Stock is a Must Own Re-Opening Play, 7 Internet of Things Stocks That Are a Perfect Fit to Our Connected Future, 7 Undervalued Stocks That Deserve More Attention, 7 Semiconductor Stocks Set to Gain From the Chip Shortage, 7 Great Dividend Stocks to Buy For a Comfortable Retirement, 7 Penny Stocks That Don’t Care About Robinhood, 7 Hotel Stocks Just Waiting For the Vaccine, 7 Stocks to Watch When Student Debt Forgiveness Gets Passed, 7 Healthcare Stocks Delivering Innovation in 2021, 7 Lithium Stocks That Will Power the Electric Vehicle Boom, 7 Electric Vehicle (EV) Stocks That Have Real Juice, Receive Analysts' Upgrades and Downgrades Daily. OCUGEN INC OCGN STOCK CHART ANALYSIS | NEW PRICE TARGET BY ANALYSIS RATINGS OF $8 ! View ocgn's stock price, price target, earnings, forecast, insider trades, and news at marketbeat. Please log in to your account or sign up in order to add this asset to your watchlist. By Dady CJ On Feb 11, 2021. The projected low price target is $0.7 while the price target rests at a high of $8. Roth Capital has the highest price target set, predicting OCGN will reach $10.00 in the next twelve months. However, Chardan Capital downgraded the stock to âNeutralâ from âBuyâ based on the recent stock price surge. Learn more. In contrast, all 3 other analysts who have recently posted an Ocugen review rate the stock a Buy. The average Ocugen stock price prediction forecasts a potential downside of N/A from the current OCGN share price ⦠Roth Capital currently has a buy rating on the stock. Cantor Fitzgerald analyst Kristen Kluska raised the firm's price target on Ocugen to $4 from $1 and keeps an Overweight rating on the shares, reflecting the potential opportunity for Covaxin. Several other equities research analysts have also recently commented on the stock. Each stock's consensus analyst rating is derived from its calculated consensus ratings score (0-1.5 = Sell, 1.5-2.5 = Hold, 2.5-3.5 = Buy, >3.5 = Strong Buy). Based on analysts offering 12 month price targets for OCGN in the last 3 months. 9:48a Moderna stock price target cut to $100 from $140 at BofA Securities 9:45a Breaking Dow up 175 points on gains in Salesforce.com Inc., Intel stocks to be replaced Ocugen target price projections below should be used in combination with other traditional price prediction techniques such as stock price forecasting, Most Ocugen analysts issue ratings four times a year, at intervals of three months. The rest of the street is faced with a similar problem; the gains have pushed the share price far beyond the $12 average price target, which sits slightly below the stockâs current trading price. When running Ocugen Inc stock analysis, check to measure Ocugen's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter. With a total of 3 Buys and 1 Hold, the analyst consensus rates Ocugen a Strong Buy. Their average twelve-month price target is $4.80, predicting that the stock has a possible downside of 46.49%. Detailed list of analyst forecasts According to . 5 things for investors to know as ocugen soars 100%+. The chart below shows how a company's share price and consensus price target have changed over time. A number of other brokerages have also recently issued reports on OCGN. There is no one specific way to measure analysis performance other than comparing it to the past results via a very sophisticated attribution analysis. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. However, the Strong Buy consensus rating is backed with a $0.9 price target, ⦠associated with market volatility, economic swings, and company-specific events. Analysts arrive at stock ratings after researching public, Ocugen's target price is an analyst's projection of its future price. Each analyst's rating is normalized to a standardized rating score of 1 (sell), 2 (hold), 3 (buy) or 4 (strong buy). Identify stocks that meet your criteria using seven unique stock screeners. Ocugen target price is determined by taking all analyst projections and averaging them out. A number of other equities analysts also recently weighed in on OCGN. Ocugen Inc. analyst estimates, including OCGN earnings per share estimates and analyst recommendations. Their average twelve-month price target is $4.80, suggesting a possible downside of 45.1%. "Following" : "Follow"}} OCGN 8.63 0.11 (1.26%). Learn about financial terms, types of investments, trading strategies and more. OCUGEN INC OCGN STOCK CHART ANALYSIS | NEW PRICE TARGET BY ANALYSIS RATINGS OF $8 ! Start Your Risk-Free Trial Subscription Here, Here’s Where Churchill Capital IV Corp (NYSE: CCIV) Stock Can Bottom, Buy DocuSign Stock Because the World Has Changed Forever, 3 Companies Leading the Fourth Industrial Revolution, Campbell Soup Company, A Recipe For Investor Gains, 3 Low-Volatility Dow Jones Stocks to Buy Now, Calavo Growers (NASDAQ:CVGW) Is Ripe For The Reopening, Oracle Stock Down 5% On Post-Earnings Weakness, Tesla Roars Back And Wall Street Likes It. Pre-Market 0.03 (0.29%) HC Wainwright & Co. Upgrades Ocugen to Buy, Announces $4.5 Price Target Benzinga Newdesk , Benzinga Staff Writer {{following ? 1y Target Est: 9.00: Fair Value is the appropriate price for the shares of a company, based on its earnings and growth rate also interpreted as when P/E Ratio = Growth Rate. We track the performance of the top 100 financial experts across various large and mid-size financial boutiques. before it wasn't. The average price target is $ 0.00 with a high estimate of $ 0.00 and a low estimate of $ 0.00 . Ocugen Inc. analyst ratings, historical stock prices, earnings estimates & actuals. Based on 4 analysts offering 12 month price targets for Ocugen in the last 3 months. MarketBeat's consensus price targets are a mean average of the most recent available price targets set by each analyst that has set a price target for the stock in the last twelve months. Ratings are usually accompanied by a target price to helps potential investors understand Ocugen stock's fair price compared to its market value. Price targets can be assigned to all types of securities, from complex investment products to stocks such as Ocugen Inc and even bonds. These New Currencies Could Be Better Than Bitcoin. 4 Wall Street analysts have set twelve-month price targets for Ocugen in the last year. Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: You have already added five stocks to your watchlist. The analyst set the price target from $4.50 to $12.00. MarketBeat's consensus ratings and consensus price targets may differ from those calculated by other firms due to differences in methodology and available data. Generally, the target price of Ocugen depends on its. When setting a price target estimate, an analyst is trying to determine what the Stock is worth and where the price will be in a year from now. Ocugen (NASDAQ:OCGN) had its target price raised by Roth Capital from $9.00 to $10.00 in a report released on Thursday morning, The Fly reports. Want to see which stocks are moving? Analyst consensus ratings scores are calculated using the mean average of the number of normalized sell, hold, buy and strong buy ratings from Wall Street analysts. You can opt out at any time. All rights reserved. On average, they expect Ocugen's share price to reach $4.80 in the next year. The current analyst and expert consensus on Ocugen is. See why this peculiar group is sparking the biggest trading opportunity of the year. Stock market 2021 predictions as per vedic astrology is based on planetary transits and reveal in detail about the nature of stock market, commodity market and companies in 2021. Ocugen (NASDAQ:OCGN) had its price target upped by Roth Capital from $1.00 to $8.00 in a report released on Wednesday morning, The Fly reports. 4 analysts have issued twelve-month target prices for Ocugen's shares. You can analyze the entity against its peers and financial market as a whole to determine factors that move Ocugen's price. Ocugen's target price is an analyst's projection of its future price. Get daily stock ideas top-performing Wall Street analysts. © American Consumer News, LLC dba MarketBeat® 2010-2021. And Roth Capital analyst Zegbeh Jallah had assigned Ocugen a âBuyâ rating. Cantor Fitzgerald also issued estimates for Ocugenâs FY2020 earnings at ($0.32) EPS and FY2021 earnings at $1.39 EPS. Anxious Dog Owners are Fueling an $89 Billion Market, Growth in one new sector is off the charts, thanks to nervous, overbearing dog owners. Several other brokerages have also commented on OCGN. Their forecasts range from $0.70 to $10.00. The even lighter blue range in the background of the two lines represents the low price target and the high price target for each stock. Ocugen price target raised to $8 from $1 at Roth Capital Roth Capital analyst Zegbeh Jallah raised the firm's price target on Ocugen to $8 from $1 and keeps a Buy rating on the shares after the company announced deal terms of its previously-disclosed agreement for co-development, supply, and U.S. commercialization of Bharat's Covaxin, a Covid vaccine developed in India. 0. Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk Share Facebook Twitter Google+ Linkedin ReddIt WhatsApp Pinterest Email Print. Ocugen (NASDAQ:OCGN) had its target price raised by Cantor Fitzgerald from $1.00 to $4.00 in a research note released on Wednesday, The Fly ⦠They currently have a buy rating on the stock. Roth Capital analyst Zegbeh Jallah raised the firm's price target on Ocugen to $8 from $1 and keeps a Buy rating on the shares after the company announced deal terms of its previously-disclosed agreement for co-development, supply, and U.S. commercialization of Bharat's Covaxin, a Covid vaccine developed in India. The average price target is $12.50 with a high forecast of $15.00 and a low forecast of $10.00. Receive a free world-class investing education from MarketBeat. The dark blue line represents the company's actual price. Most of Ocugen's stock examination focuses on studying past and present price action to predict the probability of Ocugen's future price movements. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Zacks Investment Research cut shares of Ocugen from a buy rating [â¦] The lighter blue line represents the stock's consensus price target. View, Ocugen Target Price and Analyst Consensus, Sponsored content. 4 Wall Street analysts have issued ratings and price targets for Ocugen in the last 12 months. And these three little-known coins have the potential to beat Bitcoin by up to 100X this year. But this news is rather good. Ocugen price target raised to $8 from $1 at Roth Capital. I don't care about the opinions of analysts. Their average twelve-month price target is $4.80, predicting that the stock has a possible downside of 41.46%. Learn more. As a bonus to opt-ing into our email newsletters, you will also get a free subscription to the Liberty Through Wealth e-newsletter. Modern health & wellness food stock is a power-play top 5 plant-based stock to watchdocument.write('
'); View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. After the end of a historical bull market, the cryptocurrency market is completely outpacing traditional investments. Upgrade to remove this ad. The firm currently has a buy rating on the stock. This suggests that the stock has a possible downside of 45.1%. We have many different tools that can be utilized to determine how healthy Ocugen is operating at the current time. Yesterday, Nakae took another look at Ocugen at its present share price, and declared it overpriced, downgrading the shares to Neutral (i.e. 4 Wall Street analysts that have issued a 1 year OCGN price target, ... On average, Wall Street analysts predict that . Ocugen, Inc. (OCGN) estimates and forecasts See what's happening in the market right now with MarketBeat's real-time news feed. Can Fulgent Sustain Sky-High Growth Post-Pandemic? 326 E 8th St #105, Sioux Falls, SD 57103 | [email protected] | (844) 978-6257 MarketBeat All Access subscribers can access stock screeners, the Idea Engine, data export tools, research reports, and other premium tools. MarketBeat calculates consensus analyst ratings for stocks using the most recent rating from each Wall Street analyst that has rated a stock within the last twelve months.